3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Carcinoma, Non-Small-Cell Lung
3
Stomach Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Lymphoma, Large B-Cell, Diffuse
2
Colorectal Neoplasms
2
Uterine Cervical Neoplasms
1
Thyroid Neoplasms
1
Small Cell Lung Carcinoma
1
Sarcoma
1
Rectal Neoplasms
1
Pheochromocytoma
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Paraganglioma, Extra-Adrenal
1
Pancreatic Neoplasms
1
Pancreatic Adenocarcinoma Metastatic
1
Osteosarcoma
1
Neoplasms by Histologic Type
1
Neoplasm Metastasis
1
Nasopharyngeal Neoplasms
1
Nasopharyngeal Carcinoma
1
Gynecological Cancer
1
Gastrointestinal Neoplasms
1
Gastrointestinal Diseases
1
Esophageal Squamous Cell Carcinoma
1
Digestive System Diseases
1
Carcinoma
1
Breast Neoplasms
1
Breast Neoplasm Female
1
Interventions
Cisplatin
18
Radiotherapy
9
Gemcitabine
8
Fluorouracil
8
Docetaxel
7
Paclitaxel
6
Carboplatin
5
Capecitabine
5
Radiotherapy, Intensity-Modulated
4
Oxaliplatin
4
Nivolumab
3
Endostatins
3
Bevacizumab
3
toripalimab
2
spartalizumab
2
pembrolizumab
2
endostar protein
2
apatinib
2
Cetuximab
2
Celecoxib
2
triethanolamine
1
sintilimab
1
regramostim
1
penpulimab
1
infigratinib
1
fluzoparib
1
cc-486
1
camrelizumab
1
avelumab
1
atezolizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Nasopharyngeal Neoplasms
×
penpulimab
×
Clear all
NCT05807880
2026-01-23
ALTER-HN005
Sun Yat-sen University
Phase 2
Active not recruiting
59 enrolled